Log In Create an Account

HOME
News
Business of Medicine Global Health Health Policy Health Technology
Allergy, Asthma, and Immunology Cardiology Dermatology Diabetes and Endocrinology Emergency Medicine Gastroenterology Genetics Geriatrics
Infectious Disease Nephrology Neurology Nutrition OB/GYN & Women's Health Oncology Ophthalmology Pain Management
Pediatrics Primary Care Psychiatry and Mental Health Pulmonary Medicine Radiology Rheumatology Sports Medicine Surgery
All Programs
AudioAbstracts CME/CE Clinical Practice Medical Interest Video Library
Conference Coverage Cystic Fibrosis in Focus Diabetes Discourse Global Multiple Sclerosis Academy Global Oncology Academy
Grand Rounds Nation
Online Education
Allergy and Clinical Immunology Bladder Health/Incontinence General Medicine and Primary Care Nutrition
Oncology and Hematology Pediatrics Urology
TOPICS
Allergy and Clinical Immunology Clinical Pharmacology Diabetes and Endocrinology General Medicine and Primary Care HIV/Aids and Infectious Disease
Infectious Disease Neurology and Neurosurgery Nutrition Oncology and Hematology Pediatrics
Poisoning and Drug Reference Psychiatry and Mental Health Pulmonary Medicine Radiology Urology
Meetings
Live Broadcasts

Home
Upcoming Events

The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC

Explore emerging strategies in advanced squamous NSCLC after frontline chemoimmunotherapy failure, including CTLA-4 targeting and personalized sequencing.

ReachMD Healthcare Image

Title

Terms
Privacy
About
Faculty
Contact
Cookies

GET HELP(877) 776-8211

1301 Virginia Drive, Suite 300
Fort Washington, PA 19034

© All rights reserved.

Discussion
Player

LIVE ON REACHMD RADIOBack to live radio

Loading...

00:00

00:00

On Air
Playlists

We're glad to see you're enjoying Prova Education…
but how about a more personalized experience?

Register for free

You are now leaving Prova Education and going to a site run by another organization.

Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.

Cancel Continue